ROXADUSTAT CONSISTENTLY IMPROVES HEMOGLOBIN (HB) VERSUS PLACEBO, ACHIEVING HB >= 10 G/DL IN MOST PATIENTS (PTS) WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD)

Pecoits, R; Chan, TM; Hardy, E; Little, D; Yu, P; Fishbane, S; Provenzano, R; Rastogi, A

AMERICAN JOURNAL OF KIDNEY DISEASES, 2021; 77 (4): 635